CME
Newest Emerging Data from ISTH: Andexanet Alfa vs. 4F-PCC?
August 11, 2023
Host: Paul P. Dobesh, PharmD, FACC, FAHA, FCCP, BCPS, BCCP The introduction and assessment of real-world data (RWD) associated with FXa inhibitor-related bleeds is of critical importance in treatment-emergent situations, as there has been limite
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast
Gain access to Blubrry tools that help build your podcast, including free podcast stats!